Skip to main content

Table 1 Overview of baseline characteristics in the compared groups; SD = standard deviation, MSM = men who have sex with men, HPC = patients from countries of high HIV prevalence, ART = antiretroviral therapy, IQR = interquartile range, NNRTI = antiretroviral regimen based on NNRTI, PI = antiretroviral regimen based on PI, NRTI or NNRTI/PI = antiretroviral regimen either consisting of NRTI only or including NNRTI and PI; p-values calculated by T-test, Chi-squared or Mann-Whitney-U test

From: Impaired CD4-cell immune reconstitution upon HIV therapy in patients with toxoplasmic encephalitis compared to patients with pneumocystis pneumonia as AIDS indicating disease

  TE (n = 61) PCP (n = 196) p
  n/mean %/SD n/mean %/SD  
Age 40.8 8.4 41.0 10.5 0.876
Female 16 26.2% 28 14.3% 0.031
Migrant 13 21.3% 41 20.9% 0.948
Transmission risk      
MSM 25 41.0% 114 58.2% 0.013
HPC 11 18.0% 14 7.1%  
Other 25 41.0% 68 34.7%  
ART initiation date Apr 02 (median) 34 months (IQR) Sep 01 (median) 35 months (IQR) 0.631
Firstline-ART      
NNRTI 11 18.0% 34 17.3% 0.069
PI 45 73.8% 119 60.7%  
NNRTI/PI 3 4.9% 37 18.9%  
NRTI 2 3.3% 6 3.1%  
Baseline values      
CD4/μl 60.9 44.2 44.7 42.1 0.022
CD8/μl 637.2 301.2 726.4 492.3 0.222
%CD4 6.8 4.3 4.8 3.9 0.013
%CD8 67.0 13.3 65.2 15.9 0.565
VL (log10 Kop/ml) 4.46 1.20 5.00 1.02 0.008
Lymphocytes/μl 981.8 544.1 1,056.0 887.39 0.635